Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Circ LLC is currently engaged in the prosecution of 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This activity is localized within 1 distinct art unit, reflecting a narrow administrative footprint for the company's current intellectual property efforts. The matter is assigned to 1 distinct examiner, ensuring 1 point of contact at the patent office. This concentration suggests that the company's current legal focus is directed toward 1 technical advancement.
RHOADES, DEREK JAMES is the busiest examiner for this portfolio and is responsible for the 1 pending office action. Because the portfolio involves only 1 distinct examiner and 1 distinct art unit, the prosecution path is streamlined. Practitioners can focus their efforts on the specific examination trends associated with RHOADES, DEREK JAMES without the need to reconcile conflicting feedback from multiple art units. This centralized structure allows for a specialized approach to the 1 pending matter currently under review.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RHOADES, DEREK JAMES | 1 | 71.3% | +17.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17946785 | METHOD OF AGING REGENERATED DIACID CRYSTALS | RHOADES, DEREK JAMES | 22d |
| Art Unit | Apps |
|---|---|
| 1692 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17946785 | METHOD OF AGING REGENERATED DIACID CRYSTALS | RHOADES, DEREK JAMES | 1692 | §103DP | Final Rejection | 22d | Pending | Sep 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial